Related Experiment Video
Updated: Aug 15, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
[Use of a portable drug administration system for long-term insulin administration to diabetics]
Abstract:
The efficacy of a prolonged (an average of 24.2 days) subcutaneous insulin administration using a Soviet apparatus NDL (a portable drug dosing apparatus) of paracorporal type was studied in 30 patients with type I diabetes mellitus. As a result of therapy a stable compensation of carbohydrate metabolism was achieved in 26 patients, subcompensation in 4 patients; glycemia circadian variations and requirements in insulin in most cases decreased. Simultaneously a clinical improvement of the patients' general status was observed. The use of a prolonged subcutaneous administration of insulin using the NDL was recommended for patients with insulin-dependent diabetes mellitus with a grave form, a labile course and insulin resistance that was difficult to control.
More Related Videos
09:31Sustained Administration of β-cell Mitogens to Intact Mouse Islets Ex Vivo Using Biodegradable Poly(lactic-co-glycolic acid) Microspheres
Published on: November 5, 2016
08:32Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain
Published on: January 4, 2018
Related Concept Videos
Routes of Drug Administration: Parenteral
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Oral Drug Delivery Systems: Continuous-Release Systems
Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices
Insulin Formulations: Types and Delivery
Short-acting insulins are divided into rapid-acting...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...